3-(2-methoxyphenyl)-6-nitro-2-(piperazin-1-ylmethyl)quinazolin-4(3H)-one

ID: ALA3344452

PubChem CID: 57339123

Max Phase: Preclinical

Molecular Formula: C20H21N5O4

Molecular Weight: 395.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1-n1c(CN2CCNCC2)nc2ccc([N+](=O)[O-])cc2c1=O

Standard InChI:  InChI=1S/C20H21N5O4/c1-29-18-5-3-2-4-17(18)24-19(13-23-10-8-21-9-11-23)22-16-7-6-14(25(27)28)12-15(16)20(24)26/h2-7,12,21H,8-11,13H2,1H3

Standard InChI Key:  STJZRZWTUNIPRV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   16.4084  -17.4210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4073  -18.2405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1153  -18.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1136  -17.0121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8222  -17.4174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8256  -18.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5379  -18.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2515  -18.2367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2481  -17.4115    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5312  -16.9996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5267  -16.1824    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.9546  -17.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9625  -19.4606    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2530  -19.8664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2533  -20.6800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9603  -21.0905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6687  -20.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6701  -19.8614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6999  -17.0128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9923  -17.4216    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6997  -16.1956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6628  -17.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3687  -16.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3666  -16.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6527  -15.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9497  -16.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6640  -18.2264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.9570  -18.6361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3724  -18.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  8 28  1  0
  9 12  1  0
 28 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 19 20  2  0
 19 21  1  0
  1 19  1  0
 12 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 12  1  0
 22 27  1  0
 27 29  1  0
M  CHG  2  19   1  21  -1
M  END

Associated Targets(non-human)

Venezuelan equine encephalitis virus (381 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 395.42Molecular Weight (Monoisotopic): 395.1594AlogP: 1.71#Rotatable Bonds: 5
Polar Surface Area: 102.53Molecular Species: BASEHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.21CX LogP: 1.79CX LogD: -0.01
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -1.59

References

1. Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE..  (2014)  Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.,  57  (20): [PMID:25244572] [10.1021/jm501203v]

Source